Search
TELA Bio Inc
TELAAdd to Watchlist
0.719USD
+0.042+6.18%
Market hours （ET）Quotes delayed by 15 min
32.20MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-29The current earnings forecast score of TELA Bio Inc is 8.00, ranking 66 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 4.00, with a high of 5.00 and a low of 1.25.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
2.250
Target Price
+246.15%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
TELA Bio Inc
TELA
5
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
31
Stryker Corp
SYK
31
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is TELA Bio Inc's expected revenue for the next quarter?
TELA Bio Inc's expected revenue is 20.01M.
What is TELA Bio Inc's price target?
Analysts forecast that TELA Bio Inc's price target is USD 4.00, with the highest forecast at USD 5.00 and the lowest forecast at USD 1.25.
How have TELA Bio IncTELA's recent earnings per share performed?
The market expectation was USD -0.21, while TELA Bio IncTELA's earnings per share (EPS) for the previous quarter was USD -0.17. EPS for the next quarter is expected at USD -0.18.
What is the analyst rating for TELA Bio Inc?
Based on the ratings of TELA Bio Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.